No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Zhejiang Tianyu Pharmaceutical Co., Ltd. is a global enterprise specializing in the entire lifecycle, from the innovation to the commercialization, of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company provides essential chemical building blocks for drugs targeting a diverse range of medical conditions, including cardiovascular disorders, diabetes, anti-atherosclerosis, blood coagulation issues, and asthma. In addition to its primary focus, the firm also delivers specialty chemicals and extends its services to include contract manufacturing (CMO) for other pharmaceutical entities. This Taizhou, China-based company was established in 1993.
www.tianyupharm.comNo one on the platform currently holds 300702.SZ.
No tracked institution reports a position in 300702.SZ as of their last filing.
No one on the platform has traded 300702.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 3.2% | — | — | — | ||
| Rev. Growth % | 16.4% | 3.4% | ||||
| Profit Margin % | 4.6% | 2.3% | 9.6% | |||
| Free Cash Flow Margin % | 3.8% | -12.9% | -6.0% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $3.6B | +17.2% | $0.91 | $0.91–$0.91 | — | 1 |
| 2027 | $4.4B | +21.6% | $1.22 | $1.22–$1.22 | — | 1 |
| 2028 | $5.3B | +20.4% | $1.55 | $1.55–$1.55 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 300702.SZZhejiang Tianyu Pharmaceutical Co., Ltd. | $20.74 | +1.22% | $7.2B | — |
| 000650.SZRenhe Pharmacy Co., Ltd. | $5.18 | -0.00% | $7.2B | — |
| 000756.SZShandong Xinhua Pharmaceutical Company Limited | $12.74 | +0.08% | $6.4B | — |
| 000989.SZJiuzhitang Co., Ltd. | $8.62 | +0.35% | $7.3B | — |
| 002332.SZZhejiang Xianju Pharmaceutical Co.,Ltd. | $8.54 | +0.23% | $8.4B | — |
| 300725.SZPharmaBlock Sciences (Nanjing), Inc. | $46.50 | +2.09% | $10.8B | — |
| 600252.SSGuangxi Wuzhou Zhongheng Group Co.,Ltd | $2.21 | +1.38% | $7.0B | — |
Source: Financial Modeling Prep · peers by sector/industry